PureTech Health Statistics

Total Valuation

PureTech Health has a market cap or net worth of $408.30 million. The enterprise value is $23.78 million.

Market Cap	408.30M
Enterprise Value	23.78M

Important Dates

The next estimated earnings date is Tuesday, May 6, 2025, before market open.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

PureTech Health has 239.42 million shares outstanding. The number of shares has decreased by -2.86% in one year.

Current Share Class	n/a
Shares Outstanding	239.42M
Shares Change (YoY)	-2.86%
Shares Change (QoQ)	-1.71%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	160.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	872.44
Forward PS	80.85
PB Ratio	1.33
P/TBV Ratio	1.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	50.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.68, with a Debt / Equity ratio of 0.47.

Current Ratio	3.68
Quick Ratio	3.63
Debt / Equity	0.47
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.80

Financial Efficiency

Return on equity (ROE) is -22.07% and return on invested capital (ROIC) is -15.66%.

Return on Equity (ROE)	-22.07%
Return on Assets (ROA)	-13.39%
Return on Invested Capital (ROIC)	-15.66%
Return on Capital Employed (ROCE)	-30.89%
Revenue Per Employee	$5,200
Profits Per Employee	-$916,289
Employee Count	90
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, PureTech Health has paid $12.57 million in taxes.

Income Tax	12.57M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.46% in the last 52 weeks. The beta is 0.94, so PureTech Health's price volatility has been similar to the market average.

Beta (5Y)	0.94
52-Week Price Change	-34.46%
50-Day Moving Average	17.63
200-Day Moving Average	20.00
Relative Strength Index (RSI)	50.01
Average Volume (20 Days)	11,528

Short Selling Information

Short Interest	9,715
Short Previous Month	25,187
Short % of Shares Out	0.06%
Short % of Float	n/a
Short Ratio (days to cover)	4.71

Income Statement

In the last 12 months, PureTech Health had revenue of $468,000 and -$82.47 million in losses. Loss per share was -$0.30.

Revenue	468,000
Gross Profit	-81.55M
Operating Income	-136.44M
Pretax Income	-35.17M
Net Income	-82.47M
EBITDA	-134.73M
EBIT	-136.44M
Loss Per Share	-$0.30

Full Income Statement

Balance Sheet

The company has $500.42 million in cash and $144.73 million in debt, giving a net cash position of $355.68 million or $1.49 per share.

Cash & Cash Equivalents	500.42M
Total Debt	144.73M
Net Cash	355.68M
Net Cash Per Share	$1.49
Equity (Book Value)	306.21M
Book Value Per Share	1.32
Working Capital	370.50M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-120.80M
Capital Expenditures	n/a
Free Cash Flow	-120.80M
FCF Per Share	-$0.50

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-29,152.99%
Pretax Margin	-16,536.54%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PureTech Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.86%
Shareholder Yield	2.86%
Earnings Yield	-20.20%
FCF Yield	-29.59%

Analyst Forecast

The average price target for PureTech Health is $45.00, which is 162.54% higher than the current price. The consensus rating is "Buy".

Price Target	$45.00
Price Target Difference	162.54%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	94.00%
EPS Growth Forecast (5Y)	31.01%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PureTech Health has an Altman Z-Score of 1.32. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.32
Piotroski F-Score	n/a